China’s DeepSeek shocked the world by delivering unexpected innovation at an unbelievable price in January. But this disruptive trend isn’t confined to Big Tech: It has been quietly happening in the pharmaceutical sector.

DeepSeek is looking to press home its advantage. The Chinese startup triggered a $1 trillion-plus sell-off in global equities markets last month with a cut-price AI reasoning model that outperformed many Western competitors.

DeepSeek has reopened access to its core programming interface after nearly a three-week suspension, resuming a service key to wider adoption of an AI model that’s proven remarkably popular since its emergence last month.

Chinese AI startup DeepSeek said on Wednesday that between 1630 GMT and 0030 GMT, the cost of using its API, a platform that allows developers of other apps and web products to integrate its AI models,

China’s joyful embrace of DeepSeek has gone one step deeper - extending to TVs, fridges and robot vacuum cleaners with a slew of home appliance brands announcing that their products will feature the startup’s artificial intelligence models.